HP-positive chronic gastritis
Conditions
Interventions
Investigational Group:Triple therapy
Control group:Dual therapy
Sponsors
The First Affiliated Hospital of Wenzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Age >= 18 years, regardless of gender. Meet the diagnostic criteria for chronic gastritis, with reference to the Chinese Guidelines for the Diagnosis and Management of Chronic Gastritis (2022). Positive result on the ¹³C or ¹4C urea breath test. Patients who are either receiving anti-Helicobacter pylori therapy for the first time or have a history of failed prior anti-H. pylori treatment. Signed informed consent form.
Exclusion criteria
Exclusion criteria: Individuals with a known or suspected allergy to the investigational product or any of its components. Participation in another clinical trial within the past month. Patients with a central venous catheter for intravenous infusion. Patients with fructose and lactose intolerance. Patients who are immunocompromised or hospitalized due to a critical illness or impaired immune system. Any other condition that, in the investigator's judgment, may pose a risk to the patient.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Helicobacter pylori eradication rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence and severity of adverse reactions; | — |
Countries
China
Contacts
Public ContactTanzhou Chen
The First Affiliated Hospital of Wenzhou Medical University
Outcome results
None listed